Big Data Clinical Trials Life Science 
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 1, 2024
The Indian life sciences sector is making strides by integrating quantum computing, artificial intelligence (AI), machine learning (ML), advanced analytics, big data, internet of things (IoT) and blockchain into their research and development efforts.
pharmaphorum
JANUARY 11, 2023
Over the past few decades, data generation has veritably exploded. However, the ‘Big Data paradigm’ is not so much concerned with the volume of that data, but how businesses and, indeed, industries can derive meaningful insights from what has become a glut of information. From Big Data to small.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
JANUARY 20, 2022
Life science consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of life science consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a life science consultant. Job Description.
Roots Analysis
JANUARY 28, 2024
Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
pharmaphorum
MAY 30, 2022
Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. .
pharmaphorum
MAY 25, 2021
They allow them to study the development of disease in a group of patients that are more representative of the general population than in a typical clinical trial, giving a more nuanced view of the performance of the therapy’s benefits and drawbacks. Patient-friendly studies. About Savana.
Expert insights. Personalized for you.
156 
Let's personalize your content